ADPTAdaptive Biotechnologies Corporation
$26.49+98% 1Y
$26.49
$12.4152 weeks$29.86
ADPT in its own filings
ADPT's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
118
Events found in the filings · across 824 filings · the record starts in 2019
- Hard flags
- 1
Hard flags
- Most recent filing
- Aug 4, 2026
Most recent filing · Form 10-Q
- Record starts
- Apr 25, 2019
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 4, 2026
- Delisting notice / listing-rule failurehistorical
- 2023-07-03
- SEC comment-letter activity11 occurrences
- 2020-01-21
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 29, 2026On July 24, 2026, the Company’s Chief Scientific Officer and Co-founder, Dr. Harlan Robins, decided to transition into a strategic consultant role with the Company.Earnings release · Form 8-K
- Jun 22, 20260% Convertible Senior Notes due 2031 On June 22, 2026, Adaptive Biotechnologies Corporation (the “Company”) issued $345 million in aggregate principal amount of 0% Convertible Senior Notes due 2031 (the “Notes”)Material agreement entered · Form 8-K
- Jun 15, 2026On June 15, 2026, Adaptive Biotechnologies Corporation (the “Company”) issued a press release announcing that it intends to offer, subject to market conditions and other factors, $250 million in aggregate principal amount of convertible senior notes due 2031 (the “Notes”) to persons reasonably believed to be qualified …Other event · Form 8-K
- May 5, 2026Adaptive Biotechnologies Reports First Quarter 2026 Financial Results.Earnings release · press release
- Feb 5, 2026Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
- Jan 12, 2026Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results.Earnings release · press release
- Dec 30, 2025On December 30, 2025, Adaptive Biotechnologies Corporation (the “Company”) announced that Digital Biotechnologies, Inc. (“Digital Biotechnologies”), a 70% owned subsidiary of the Company, held an initial closing of its Series A Preferred Stock financing, with total anticipated proceeds in the financing round of up to …Other event · Form 8-K
- Nov 5, 2025Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Diagnostics & Research
Ranks #13 of 21 by RyuScore